J3245 is the HCPCS code for: Injection, tildrakizumab, 1 mg. In 2024, 265 providers billed J3245 1,278,409 times, with an estimated $137.0M paid by Medicare.
J3245 is a Part B drug code: Medicare pays an ASP-based rate of $124.27 per 1 mg (2026 Q3 ASP drug pricing file). Total payment per patient depends on the dose billed.
A billed "service" on this code is one 1 mg unit, not one patient visit — that's why the service counts below run high.
What Medicare actually paid per service in 2024, on average: $107.14 (observed payment across all settings and modifiers — not a fee-schedule rate).
The top 5 billers nationally, ranked by 2024 Medicare service volume.
| # | Provider | Specialty | Location | Services | Est. Medicare paid |
|---|---|---|---|---|---|
| 1 | Daniel Shrager, M.D. | Dermatology | Sellersville, PA | 18,400 | $2.0M |
| 2 | Robert Singh, M.D. | Vascular Surgery | Philadelphia, PA | 18,100 | $1.9M |
| 3 | Suleman Bangash, DO | Dermatology | Elgin, IL | 16,200 | $1.7M |
| 4 | Jeffrey Crowley, M.D. | Dermatology | Bakersfield, CA | 14,500 | $1.6M |
| 5 | Robert Brennan, MD | Infectious Disease | Lynchburg, VA | 13,900 | $1.5M |
Prospect 811 answers "what is this code, what does it pay, and who bills it?" for every billable code — then filters the answer to your exact territory, with phone numbers. $79/month, no contract, 14-day refund.
Start prospecting →